National Bank of Canada’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
National Bank of Canada's VRTX Position: Q2 2026 in Review
National Bank of Canada reduced its Vertex Pharmaceuticals (VRTX) stake by 36% in Q2 2026, selling an estimated $44M and leaving 172,898 shares worth $85.9M. The position accounts for 0.06% of the portfolio, ranked #237.
National Bank of Canada first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $122M in Q1 2026. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- National Bank of Canada held 172,898 shares of Vertex Pharmaceuticals worth $85.9M as of Q2 2026.
- National Bank of Canada sold 99,219 Vertex Pharmaceuticals shares in Q2 2026, an estimated $44M.
- Vertex Pharmaceuticals made up 0.06% of National Bank of Canada's portfolio in Q2 2026, its #237 holding.
- National Bank of Canada first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- National Bank of Canada's Vertex Pharmaceuticals position peaked at $122M in Q1 2026.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.